These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23961280)

  • 21. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcranial sonography image characteristics in different Parkinson's disease subtypes.
    Sheng AY; Zhang YC; Sheng YJ; Wang CS; Zhang Y; Hu H; Luo WF; LIu CF
    Neurol Sci; 2017 Oct; 38(10):1805-1810. PubMed ID: 28726052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study.
    Miyamoto M; Miyamoto T
    Sleep Med; 2020 Apr; 68():31-34. PubMed ID: 32018190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
    Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
    Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Tan YY; Chen SD
    Transl Neurodegener; 2018; 7():15. PubMed ID: 30062008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midbrain transcranial sonography in Korean patients with Parkinson's disease.
    Kim JY; Kim ST; Jeon SH; Lee WY
    Mov Disord; 2007 Oct; 22(13):1922-6. PubMed ID: 17588240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of Transcranial Sonography for Evaluating Substantia Nigra Hyper-echogenicity in Patients with Parkinson's Disease.
    Xu R; Chen G; Mao Z; Gao H; Deng Y; Tao A
    Ultrasound Med Biol; 2020 May; 46(5):1208-1215. PubMed ID: 32102740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
    Walter U
    Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.
    Zhang S; Tao K; Wang J; Duan Y; Wang B; Liu X
    Front Cell Neurosci; 2020; 14():216. PubMed ID: 32848616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.
    Richter D; Woitalla D; Muhlack S; Gold R; Tönges L; Krogias C
    J Neuroimaging; 2017 Sep; 27(5):524-530. PubMed ID: 28426143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
    Walter U
    J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
    Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
    Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.
    Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T
    Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.